Gaba 300-ezs Kit
Product Images NDC 59088-725

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Gaba 300-ezs (NDC 59088-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puretek Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Gaba 300 Carton)

Packaging label for Gaba 300-EZS, a human prescription drug kit containing Gabapentin capsules, USP 300 mg (100 count) and a 2 fl oz (59 mL) pill swallowing spray. The label is primarily white with purple highlight bands stating 'Gaba 300-EZS' and includes storage instructions and manufacturer information for PureTek Corporation.*

FDA Label Image

1 (Image 1)

A formula for calculating creatinine clearance (CLCr) adjusted for age, weight, gender, and serum creatinine level (mg/dL). It includes a factor for female patients and uses weight in kilograms and age in years.*

FDA Label Image

1 (Image 10)

Gaba 300-EZS kit by PureTek Corporation. The packaging prominently displays the brand name "GABA 300-EZS" and the generic name Gabapentin. The label indicates it is a kit dosage form, featuring blue and white coloration with branding and regulatory text typical for prescription drug packaging.*

FDA Label Image

1 (Image 11)

Gaba 300-EZS kit packaging label by PureTek Corporation. The kit is a human prescription drug containing the generic ingredient Gabapentin. The label prominently displays the proprietary name Gaba 300-EZS with no visible strength or detailed dosage information.*

FDA Label Image

1 (Image 12)

Gaba 300-EZS kit by PureTek Corporation with product NDC 59088-725. The label features the proprietary name Gaba 300-EZS and identifies gabapentin as the active ingredient, presented as a prescription drug kit.*

FDA Label Image

1 (Image 2)

Gaba 300-EZS kit by PureTek Corporation featuring Gabapentin as the active ingredient. The image shows a blister card with 10 round, white tablets arranged in two rows of five. The packaging is printed with the product name and labeler information.*

FDA Label Image

1 (Image 3)

Gaba 300-EZS Kit containing Gabapentin, a human prescription drug by PureTek Corporation. The label shows the brand and generic names clearly, with a simple blue and yellow design on the packaging. The product NDC is 59088-725.*

FDA Label Image

1 (Image 4)

Gaba 300-EZS gabapentin kit packaging label from PureTek Corporation. The kit contains 4 blister packs, each with 60 tablets of 300 mg gabapentin. The label prominently shows the product name, dosage strength, kit contents, and manufacturer.*

FDA Label Image

1 (Image 5)

Chemical structure of gabapentin, showing a cyclohexane ring attached to amino (CH2NH2) and carboxymethyl (CH2CO2H) functional groups.*

FDA Label Image

1 (Image 6)

A line graph showing mean pain scores over 8 weeks comparing placebo and gabapentin 3600 mg/day. The x-axis represents time in weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. Gabapentin shows a decreased mean pain score over time, while placebo remains relatively steady.*

FDA Label Image

2 (Image 7)

A line graph depicting mean pain scores over 7 weeks, comparing placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

3 (Image 8)

A bar graph comparing percentages for placebo (PBO) and gabapentin (GBP) at different doses in two separate studies. Study 1 shows 12% for PBO and 29% for GBP 3600. Study 2 shows 14% for PBO, 32% for GBP 1800, and 34% for GBP 2400, with statistical significance indicated by p-values below 0.01 and 0.001.*

FDA Label Image

4 (Image 9)

A scatter plot showing the percentage difference versus daily dose (mg) for three studies labeled a, b, and c. The daily dose ranges from 600 to 1800 mg, with differences varying between approximately 7% and 18%. The legend identifies black squares as Study a, gray squares as Study b, and white squares as Study c.*

FDA Label Image

Image Description (Pill Swallowing Spray)

This image shows the Nutrition Facts and product information panel for Gaba 300-EZS Pill Swallowing Spray. It includes a nutritional table with zero calories and no fats, sugars, or protein, ingredients list, and directions for use to coat the tongue and throat before swallowing pills. The volume is 2 fl oz (59 mL), and it is labeled by PharmaPureRx and manufactured by PureTek Corporation in San Fernando, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.